long intergenic non-protein coding RNA 2709Genealiases: []
Q-omics provides the consensus-scored LINC02709 profile across patient tissues and cancer cell-line models. LINC02709 expression is associated with patient survival in 25 of 34 cancer types, with the highest sampling consensus in BLCA. Among the 18 cancer types available for tumor–normal comparison, LINC02709 is differentially expressed in 15, with the highest sampling consensus in KIRC. Additionally, LINC02709 RNA expression shows 17,929 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight BLCA, KIRC, and TGCT as cancer lineages where LINC02709 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02709 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02709 survival associations across molecular data types. LINC02709 RNA expression shows survival associations in the most cancer types (25). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02709 RNA expression–survival associations across cancer types. High LINC02709 expression shows unfavorable associations in BLCA, LIHC, LGG, KIRP and KICH, but favorable associations in READ. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for LINC02709 RNA expression.
This table summarizes LINC02709 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 15. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02709. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02709 shows higher tumor expression in KIRC, HNSC, BLCA, LUAD, KIRP and KICH. The KIRC box plot shows higher LINC02709 RNA expression in tumor versus normal tissue (log2 FC = +0.854, t-test p < 0.001).
This table shows molecular features associated with LINC02709 in patient tissues and cancer cell lines. In patient samples, LINC02709 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
